Lonza Regulatory Services - Small Molecules

Today timelines for drug development are getting shorter and shorter with 40% of approvals being expedited. In order to keep up with the tempo and stay ahead of competition every link of the chain from research, drug substance/drug product development and manufacturing needs to be in-sync. Timely and proper documentation and communication with the appropriate regulatory authorities can make a difference. To learn more, please read our technical brief.